Use of ketamine in Super Refractory Status Epilepticus: a systematic review.

Aayush AdhikariSushil Kumar YadavGaurav NepalRoshan AryalPratik BaralPeter NeupaneAadesh PaudelBarsha PanthaSulav AcharyaGentle Sundar ShresthaRamesh Khadayat

Published in: Neurological research and practice (2024)

Ketamine demonstrates safety and effectiveness in SRSE, offering advantages over GABAergic drugs by acting on NMDA receptors, providing neuroprotection, and reducing vasopressor requirement.

Keyphrases

pain management
randomized controlled trial
systematic review
brain injury
cerebral ischemia
drug induced